Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1068
|
| pubmed:dateCreated |
1998-8-26
|
| pubmed:abstractText |
To investigate a unique and critical step in retroviral gene expression not yet targeted for anti-viral therapy and to validate its potential as a site for anti-HIV intervention with a new group of therapeutic drugs.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0028-8446
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
26
|
| pubmed:volume |
111
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
222-4
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading | |
| pubmed:year |
1998
|
| pubmed:articleTitle |
A novel strategy to interfere with human immunodeficiency virus type 1 propagation.
|
| pubmed:affiliation |
Department of Biochemistry, University of Otago, Dunedin.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|